Previous Article
Molecular and Cellular Biology, February 2005, p. 1569-1575, Vol. 25, No. 4
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.4.1569-1575.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Activation of SOCS-3 by Resistin
Claire M. Steppan,1*
Juan Wang,1
Eileen L. Whiteman,1,2
Morris J. Birnbaum,1,2 and
Mitchell A. Lazar1*
Division of Endocrinology, Diabetes, and Metabolism, Penn Diabetes Center and The Cox Institute,1
Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania2
Received 14 May 2004/
Returned for modification 29 June 2004/
Accepted 10 November 2004
Resistin is an adipocyte hormone that modulates glucose homeostasis. Here we show that in 3T3-L1 adipocytes, resistin attenuates multiple effects of insulin, including insulin receptor (IR) phosphorylation, IR substrate 1 (IRS-1) phosphorylation, phosphatidylinositol-3-kinase (PI3K) activation, phosphatidylinositol triphosphate production, and activation of protein kinase B/Akt. Remarkably, resistin treatment markedly induces the gene expression of suppressor of cytokine signaling 3 (SOCS-3), a known inhibitor of insulin signaling. The 50% effective dose for resistin induction of SOCS-3 is
20 ng/ml, close to levels of resistin in serum. Association of SOCS-3 protein with the IR is also increased by resistin. Inhibition of SOCS function prevented resistin from antagonizing insulin action in adipocytes. SOCS-3 induction is the first cellular effect of resistin that is independent of insulin and is a likely mediator of resistin's inhibitory effect on insulin signaling in adipocytes.
* Corresponding author. Present address for Claire M. Steppan: Pfizer Inc., PRGD, MS220-3145, Eastern Point Rd., Groton, CT 06340. Phone: (860) 686-2717. Fax: (860) 715-4610. E-mail:
claire.m.steppan{at}pfizer.com. Mailing address for Mitchell A. Lazar: University of Pennsylvania School of Medicine, CRB 611, 415 Curie Blvd., Philadelphia, PA 19104. Phone: (215) 898-0198. Fax: (215) 898-5408. E-mail:
lazar{at}mail.med.upenn.edu.
* Corresponding author. Present address for Claire M. Steppan: Pfizer Inc., PRGD, MS220-3145, Eastern Point Rd., Groton, CT 06340. Phone: (860) 686-2717. Fax: (860) 715-4610. E-mail: claire.m.steppan{at}pfizer.com. Mailing address for Mitchell A. Lazar: University of Pennsylvania School of Medicine, CRB 611, 415 Curie Blvd., Philadelphia, PA 19104. Phone: (215) 898-0198. Fax: (215) 898-5408. E-mail: lazar{at}mail.med.upenn.edu.
Supplemental material for this article may be found at http://mcb.asm.org/.
Molecular and Cellular Biology, February 2005, p. 1569-1575, Vol. 25, No. 4
0022-538X/05/$08.00+0 doi:10.1128/MCB.25.4.1569-1575.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Steinberg, G. R., Kemp, B. E.
(2009). AMPK in Health and Disease. Physiol. Rev.
89: 1025-1078
[Abstract]
[Full Text]
-
Jorgensen, S. B., Honeyman, J., Oakhill, J. S., Fazakerley, D., Stockli, J., Kemp, B. E., Steinberg, G. R.
(2009). Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation. Am. J. Physiol. Endocrinol. Metab.
297: E57-E66
[Abstract]
[Full Text]
-
Hausman, G. J., Dodson, M. V., Ajuwon, K., Azain, M., Barnes, K. M., Guan, L. L., Jiang, Z., Poulos, S. P., Sainz, R. D., Smith, S., Spurlock, M., Novakofski, J., Fernyhough, M. E., Bergen, W. G.
(2009). BOARD-INVITED REVIEW: The biology and regulation of preadipocytes and adipocytes in meat animals. J ANIM SCI
87: 1218-1246
[Abstract]
[Full Text]
-
Cohen, G., Ilic, D., Raupachova, J., Horl, W. H.
(2008). Resistin Inhibits Essential Functions of Polymorphonuclear Leukocytes. J. Immunol.
181: 3761-3768
[Abstract]
[Full Text]
-
Vazquez, M. J., Gonzalez, C. R., Varela, L., Lage, R., Tovar, S., Sangiao-Alvarellos, S., Williams, L. M., Vidal-Puig, A., Nogueiras, R., Lopez, M., Dieguez, C.
(2008). Central Resistin Regulates Hypothalamic and Peripheral Lipid Metabolism in a Nutritional-Dependent Fashion. Endocrinology
149: 4534-4543
[Abstract]
[Full Text]
-
Huang, X., Moore, D. J., Ketchum, R. J., Nunemaker, C. S., Kovatchev, B., McCall, A. L., Brayman, K. L.
(2008). Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation. Endocr. Rev.
29: 603-630
[Abstract]
[Full Text]
-
Lee, M.-J., Lin, H., Liu, C.-W., Wu, M.-H., Liao, W.-J., Chang, H.-H., Ku, H.-C., Chien, Y.-S., Ding, W.-H., Kao, Y.-H.
(2008). Octylphenol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor and extracellular signal-regulated kinase pathways. Am. J. Physiol. Cell Physiol.
294: C1542-C1551
[Abstract]
[Full Text]
-
Kim, S.-J., Nian, C., McIntosh, C. H. S.
(2007). Resistin Is a Key Mediator of Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Lipoprotein Lipase (LPL) Activity in Adipocytes. J. Biol. Chem.
282: 34139-34147
[Abstract]
[Full Text]
-
Singhal, N. S., Lazar, M. A., Ahima, R. S.
(2007). Central Resistin Induces Hepatic Insulin Resistance via Neuropeptide Y. J. Neurosci.
27: 12924-12932
[Abstract]
[Full Text]
-
Qatanani, M., Lazar, M. A.
(2007). Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev.
21: 1443-1455
[Abstract]
[Full Text]
-
Harmancey, R., Senard, J.-M., Rouet, P., Pathak, A., Smih, F.
(2007). Adrenomedullin Inhibits Adipogenesis Under Transcriptional Control of Insulin. Diabetes
56: 553-563
[Abstract]
[Full Text]
-
Torisu, T., Sato, N., Yoshiga, D., Kobayashi, T., Yoshioka, T., Mori, H., Iida, M., Yoshimura, A.
(2007). The dual function of hepatic SOCS3 in insulin resistance in vivo.. GENES CELLS
12: 143-154
[Abstract]
[Full Text]
-
Kusminski, C. M., da Silva, N. F., Creely, S. J., Fisher, F. M., Harte, A. L., Baker, A. R., Kumar, S., McTernan, P. G.
(2007). The in Vitro Effects of Resistin on the Innate Immune Signaling Pathway in Isolated Human Subcutaneous Adipocytes. J. Clin. Endocrinol. Metab.
92: 270-276
[Abstract]
[Full Text]
-
Qi, Y., Nie, Z., Lee, Y.-S., Singhal, N. S., Scherer, P. E., Lazar, M. A., Ahima, R. S.
(2006). Loss of Resistin Improves Glucose Homeostasis in Leptin Deficiency. Diabetes
55: 3083-3090
[Abstract]
[Full Text]
-
Sands, W. A., Woolson, H. D., Milne, G. R., Rutherford, C., Palmer, T. M.
(2006). Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells.. Mol. Cell. Biol.
26: 6333-6346
[Abstract]
[Full Text]
-
Chen, Y.-H., Lee, M.-J., Chang, H.-H., Hung, P.-F., Kao, Y.-H.
(2006). 17{beta}-Estradiol Stimulates Resistin Gene Expression in 3T3-L1 Adipocytes via the Estrogen Receptor, Extracellularly Regulated Kinase, and CCAAT/Enhancer Binding Protein-{alpha} Pathways. Endocrinology
147: 4496-4504
[Abstract]
[Full Text]
-
Nair, M. G., Guild, K. J., Artis, D.
(2006). Novel Effector Molecules in Type 2 Inflammation: Lessons Drawn from Helminth Infection and Allergy. J. Immunol.
177: 1393-1399
[Full Text]
-
Spangenburg, E. E., Brown, D. A., Johnson, M. S., Moore, R. L.
(2006). Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression. J. Physiol.
572: 839-848
[Abstract]
[Full Text]
-
Liu, H.-S., Chen, Y.-H., Hung, P.-F., Kao, Y.-H.
(2006). Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway. Am. J. Physiol. Endocrinol. Metab.
290: E273-E281
[Abstract]
[Full Text]
-
Graveleau, C., Zaha, V. G., Mohajer, A., Banerjee, R. R., Dudley-Rucker, N., Steppan, C. M., Rajala, M. W., Scherer, P. E., Ahima, R. S., Lazar, M. A., Abel, E. D.
(2005). Mouse and Human Resistins Impair Glucose Transport in Primary Mouse Cardiomyocytes, and Oligomerization Is Required for This Biological Action. J. Biol. Chem.
280: 31679-31685
[Abstract]
[Full Text]
-
Barb, D., Wadhwa, S. G., Kratzsch, J., Gavrila, A., Chan, J. L., Williams, C. J., Karchmer, A. W., Mantzoros, C. S.
(2005). Circulating Resistin Levels Are Not Associated with Fat Redistribution, Insulin Resistance, or Metabolic Profile in Patients with the Highly Active Antiretroviral Therapy-Induced Metabolic Syndrome. J. Clin. Endocrinol. Metab.
90: 5324-5328
[Abstract]
[Full Text]